文献速递肝胆胰外科胃肠外科

腹腔镜胰十二指肠切除术改变壶腹部肿瘤的治疗方式

Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms.
PubMed 文献 · Surg Endosc · 2017-08-04

本研究回顾性比较了2012年6月至2016年8月间47例壶腹部肿瘤患者接受开腹胰十二指肠切除术(OPD,n=25)与全腹腔镜胰十二指肠切除术(TLPD,n=22)的围手术期及肿瘤学结局。TLPD组失血量更少(300 vs 500 mL,p<0.001)、手术时间更短(314 vs 359 min,p=0.024),且腹腔脓肿发生率更低(0 vs 16.0%,p=0.049),两组在胰瘘、胆漏、胃排空延迟、伤口感染、住院时间和再入院率上无差异。中位随访25个月,无进展生存期和总生存期无差异。

要点

  • TLPD治疗壶腹部肿瘤可减少失血量、缩短手术时间并降低腹腔脓肿发生率。
  • TLPD与OPD在胰瘘、胆漏等主要并发症及住院时间上无显著差异。
  • 中位随访25个月,两组无进展生存期和总生存期无差异。

核心结论

  • 对于壶腹部肿瘤患者,TLPD相比传统开腹手术改善了围手术期结局,且短期和长期肿瘤学结局相当。

研究设计与样本

  • 回顾性队列研究,纳入2012年6月至2016年8月间47例壶腹部肿瘤患者,其中OPD组25例,TLPD组22例。

主要发现

  • TLPD组失血量显著少于OPD组(300 vs 500 mL,p<0.001)。
  • TLPD组手术时间显著短于OPD组(314 vs 359 min,p=0.024)。
  • TLPD组腹腔脓肿发生率显著低于OPD组(0 vs 16.0%,p=0.049)。
  • 两组在胰瘘、胆漏、胃排空延迟、伤口感染、住院时间和再入院率上无显著差异(均p>0.05)。
  • 中位随访25个月,腺癌患者中两组无进展生存期和总生存期无差异。

关键数值与推荐

  • TLPD组无中转开腹,两组均无围手术期死亡。
  • 腺癌患者中两组病理特征无差异(p>0.05),所有患者切缘阴性。
  • TLPD比例逐年增加,从2012年0%升至2015年50%。

临床怎么用

  • 在具备腹腔镜技术条件的中心,TLPD可作为壶腹部肿瘤胰十二指肠切除术的安全选择。
  • TLPD可能减少失血和腹腔脓肿,但需注意患者选择及术者经验。

局限性

  • 回顾性研究设计,样本量较小(共47例),可能存在选择偏倚。
  • 中位随访时间较短(25个月),长期肿瘤学结局需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study is to present the largest reported series comparing open pancreaticoduodenectomy (OPD) to total laparoscopic pancreaticoduodenectomy (TLPD) in patients with ampullary neoplasms. METHODS: Patients undergoing OPD or TLPD for ampullary neoplasms from June 2012 to August 2016 were retrospectively identified. Perioperative outcomes were compared using a Wilcoxon rank-sum test, Student's t test, and Chi square analysis where appropriate. Kaplan-Meier estimates for progression-free survival (PFS) and overall survival (OS) were compared between the groups using the log-rank test. RESULTS: We identified 47 patients with ampullary neoplasms (adenocarcinoma n = 36, neuroendocrine tumor n = 7, undifferentiated n = 1, adenoma n = 3) undergoing OPD (n = 25) and TLPD (n = 22). The proportion of patients being offered TLPD has progressively increased every year over 5 years: 0% (2012) to 50% (2015). There were no differences in baseline variables between the two groups. TLPD was associated with less blood loss (300 vs. 500 mL, p < 0.001) and shorter operative times (314 vs. 359 min, p = 0.024). No patient required conversion to an open procedure and there were no perioperative deaths in either group. TLPD was associated with lower rates of intra-abdominal abscess (0 vs. 16.0%, p = 0.049), but there were no differences in rates of pancreatic fistula, bile leak, delayed gastric emptying, wound infection, length of stay, and readmission (all p > 0.05). Among patients with adenocarcinoma, there was no difference in pathological features between the two groups (p > 0.05) and all patients had negative margins. At a median follow up of 25 months, there was no difference in PFS or OS between the two groups. CONCLUSIONS: TLPD in patients with ampullary neoplasms results in improved perioperative outcomes while having equivalent short and long-term oncologic outcomes compared to the traditional open approach.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Chapman BC, Gleisner A, Ibrahim-Zada I, et al. Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms. Surg Endosc. 2017. PMID: 28779245. doi:10.1007/s00464-017-5766-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。